At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 48 enrolled
Drug / intervention
Dydrogesterone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Oral Dydrogesterone as Adjunctive Therapy in the Management of Preterm Labor: A Randomized, Double Blinded, Placebo-controlled Trial
In Brief
A Phase 4 clinical trial evaluating Dydrogesterone and placebo for Preterm Labor. Completed, enrolled 48 participants across 1 site.
Detailed Summary
This study evaluates the addition of oral dydrogesterone to standard treatment in the treatment of preterm labor. Half of participants will receive oral dydrogesterone and standard treatment, while the other half will receive oral placebo and standard treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPreterm Labor
CountriesThailand
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
First PostedMay 2019
Enrollment StartMay 2019
Primary CompletionMay 2020
TodayJul 2026
First PostedMay 2, 2019
Enrollment StartMay 11, 2019
Primary CompletionMay 31, 2020
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 7.2 years ago
Interventions
Dydrogesteronedrug
dydrogesterone capsule
placebodrug
placebo capsule